Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Drug Shortage Reg Adds More Manufacturers, Products To Notification List

Executive Summary

Interim final rule redefines the terms “sole manufacturer” and “discontinuance.”

You may also be interested in...



Drug Shortage Prevention May Fall To Payers As FDA Rolls Out New Reg

Even as agency touts its progress and expands its powers, it acknowledges the limits of notification.

Compounding: How Does FDA Expand Oversight Without Legislation?

After House Republicans indicate legislation expanding agency’s oversight of compounding is unlikely, FDA could consider other regulatory options, like changing internal policies or hoping a court clarifies its regulatory authority.

Compounding: How Does FDA Expand Oversight Without Legislation?

After House Republicans indicate legislation expanding agency’s oversight of compounding is unlikely, FDA could consider other regulatory options, like changing internal policies or hoping a court clarifies its regulatory authority.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS054047

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel